Navigation Links
Micromet, Inc. Reports Fourth Quarter and Full Year 2007 Financial Results
Date:3/13/2008

from Merck Serono following the completion of two phase 2 clinical trials for adecatumumab. Total operating expenses were $13.1 million for the three months ended December 31, 2007, compared to $10.9 million for the same period in 2006. For the three months ended December 31, 2007, Micromet reported a net loss of $3.8 million, or $0.09 per basic and diluted share, compared to net income of $3.4 million, or $0.11 per basic and diluted share, for the same period in 2006. The positive net income in 2006 was due primarily to the milestone payment received from Merck Serono.

Year Ended December 31, 2007

Revenues for the year ended December 31, 2007 were $18.4 million, compared to $27.6 million for 2006. For the year ended December 31, 2007, Micromet reported operating expenses of $43.6 million, compared to $61.2 million for the same period in 2006. In connection with the merger with CancerVax, Micromet recorded a non-recurring, non-cash charge of $20.9 million in the second quarter of 2006 due to the immediate write-off of CancerVax's in- process research and development programs. For the year ended December 31, 2007, net loss was $20.1 million, or $0.55 per basic and diluted share, compared to $34.0 million, or $1.29 per basic and diluted share, for 2006.

Micromet's cash and cash equivalents were $27.1 million as of December 31, 2007. Net cash used in operating activities was $14.3 million for the year ended December 31, 2007 and $15.4 million in 2006. Based on the status of our development programs, management believes that the cash balance at December 31, 2007 is sufficient to fund operations into the second quarter of 2009.

2008 Outlook:

-- Micromet will present an update on its proprietary BiTE antibody

technology platform and new BiTE antibody programs at the conference of

the American Association of Cancer Research (AACR) in April 2008.

-- A phase 1/2 clinical trial evaluating MT103 in patients wi
'/>"/>

SOURCE Micromet, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Micromet, Inc. to Host Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2007 Financial Results
2. Micromet, Inc. Elects Joseph P. Slattery to Board of Directors
3. Micromet, Inc. to Present at the Sal. Oppenheim 2nd European Healthcare Conference
4. Sunesis Pharmaceuticals Reports Fourth Quarter and Full-Year 2007 Financial Results
5. Peregrine Pharmaceuticals Reports Financial Results for the Third Quarter of Fiscal Year 2008
6. Helix BioPharma reports Q2 2008 highlights, financial results
7. Oncothyreon reports full year and fourth quarter 2007 financial results
8. Palatin Technologies, Inc. Reports Positive Results of a Phase I Clinical Study With PL-3994 for the Treatment of Congestive Heart Failure
9. Alfacell Reports Financial Results for Second Quarter of Fiscal 2008
10. ISTA Pharmaceuticals Reports Fourth Quarter and Full-Year 2007 Financial Results
11. Oncolytics Biotech Inc. Reports Highlights and Financial Results for 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... PA (PRWEB) July 22, 2014 Two ... Center’s Board of Directors at its annual Shareholders Meeting ... Chief Information Officer of The PFM Group, and Stephen ... Science Center also announced the election of Michael A. ... Board Vice Chair and Richard P. Jaffe, Esq., of ...
(Date:7/22/2014)... , Cina, 22 luglio 2014 BGI ... BGI, la maggiore organizzazione di genomica del mondo, ha ... sequenziamento dell,intero esoma umano con base la piattaforma leader ... Genomics, molto apprezzata nel settore per essere in grado ... di precisione e una rilevazione altamente sensibile di tutti ...
(Date:7/22/2014)... 2014 In chemical and petrochemical ... common sight. The rapid rise of TDL analyzers ... established as a core gas measurement technology, and ... them the gas analyzer technology of choice for ... in some processes have limited their application range. ...
(Date:7/22/2014)... SPRING, Md. , July 22, 2014 /PRNewswire/ ... announced today that it will release its second ... Tuesday, July 29, 2014. United Therapeutics ... 29, 2014, at 9:00 a.m. Eastern Time.  The ... callers dialing 1-970-315-0533.  A rebroadcast of the teleconference ...
Breaking Biology Technology:Two New Members Elected to University City Science Center Board of Directors 2Two New Members Elected to University City Science Center Board of Directors 3BGI Tech lancia un servizio di sequenziamento dell'intero esoma umano sulla piattaforma avanzata di Complete Genomics 2METTLER TOLEDO Shows How Tunable Diode Lasers (TDLs) Can Be Installed Where No TDLs Have Gone Before 2
... biotech infrastructure has prompted a Minnesota company to consider ... could employ approximately 200 people. , , Excorp Medical ... Wisconsin to manufacture systems used to treat human liver ... a product that company representatives say has the potential ...
... and growth of the medical device industry and some of ... the leading players in this $100 billion industry. , , ... this table, here are a couple interesting observations: , , ... business (with the exception of the imaging market), which includes ...
... more Wisconsin companies are expected to pitch their businesses ... , ,Eight companies from Wisconsin are now listed as ... will be in Minneapolis. , ,The forum, created ... and the Biotechnology Industry Organization, annually showcases biotech and ...
Cached Biology Technology:Minneapolis company sets sights on southern Wisconsin 2Minneapolis company sets sights on southern Wisconsin 3Midwest plays key role in developing new medical device companies 2Midwest plays key role in developing new medical device companies 3Three more Wisconsin firms to present at venture forum 2
(Date:7/22/2014)... split light with uncanny precision are key parts ... that manipulate light instead of electricity. But producing ... them with a precise beam of electrons, is ... at Princeton and Columbia universities have proposed a ... and grow these specialized materials, known as photonic ...
(Date:7/22/2014)... -- Stem cells offer much promise for treating damaged ... cell survival is poor, limiting their effectiveness. New methods ... and optimize their therapeutic function after transplantation, as described ... , a peer-reviewed journal from Mary Ann Liebert, Inc., ... BioResearch Open Access website . , ...
(Date:7/22/2014)... NY -- As part of a multinational, collaborative effort, ... Sinai have helped identify over 100 locations in the ... in the largest genomic study published on any psychiatric ... published online in Nature , point to biological ... lead to new approaches to treating the disorder, which ...
Breaking Biology News(10 mins):Technique simplifies the creation of high-tech crystals 2Technique simplifies the creation of high-tech crystals 3Mount Sinai scientists and international team shed new light on schizophrenia 2Mount Sinai scientists and international team shed new light on schizophrenia 3
... UK has been given the go-ahead to explore one of ... deep beneath Antarctica,s ice sheet. Buried under 3 km of ... may have been isolated for hundreds of thousands of ... hopes the exploration will yield vital clues about life on ...
... Moose has developed a corn plant with enormous potential for ... Moose said, due to a greater number of leaves and ... crop. The gene known as Glossy 15 was originally ... coating that acts like a sun screen for the young ...
... survey of airborne fungi and fungal spores found in Eastern ... cause of the high incidence of childhood asthma in this ... issue of the International Journal of Environmental Technology and ... human factors that lead to high levels of such fungi. ...
Cached Biology News:Final frontier: Mission to explore buried ancient Antarctic lake given green light 2Doubling a gene in corn results in giant biomass 2Airborne asthma allergens 2
... muscle cell specific protein, is reported to be ... as intestine, lung and uterus. It shares structural ... expression has been reported in most tissues that ... forms. It is also reported to be expressed ...
PC based system for superior chemifluorescent, chemiluminescent, fluorescent and colorimetric, microarray and microscope imaging and analysis....
Request Info...
... Round Well Plate Sterile ... wide range of 384-well ... high-throughput screening and research. ... assays and are suitable ...
Biology Products: